News
![Mariana Oncology's chief executive Simon Read](/sites/default/files/styles/x_large/public/2024-05/Simon_Read_Mariana.jpg?itok=-4Ac48Uj)
Novartis digs deeper in radiopharma with $1.75bn Mariana buy
Novartis has struck another deal to strengthen its position in radiopharmaceuticals, agreeing to pay $1 billion upfront for radioligand therapy (RLT) developer Mariana Onc